POU2F2 and diffuse large B-cell lymphoma: Recurrent missense mutations reduce Pou2f2 transactivation activity and B lymphoma cell lines expressing these have a survival advantage20, conversely DLBCL cell lines appear to be addicted to POU2F2 expression21.